CHICAGO (WLS) -- A new COVID19 test that provides results in five minutes is set to roll out soon as Illinois-based Abbott Labs expected to deliver 50,000 tests per-day. President Donald Trump did a ...

Abbott Labs got emergency approval from the US Food and Drug Administration for its rapid antigen test, which can detect a Covid-19 infection in 15 minutes. The test is a "game changer," according to ...

On Wednesday, Abbott Laboratories (NYSE:ABT) reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11.01 billion. Organic sales growth for the underlying ...

Abbott Labs' third-quarter results were boosted boosted by strength in the company's medical-devices business Abbott Laboratories on Wednesday reported better-than-expected third-quarter earnings and ...

Abbott Laboratories posted lower-than-expected sales in its latest quarter, dented in part by diminished demand for Covid-19 testing-related products. The healthcare-products manufacturer logged ...

Abbott Laboratories (NYSE:ABT) on Wednesday reported first-quarter sales of $10.36 billion, up 7.2% year over year, almost in line with the consensus of $10.40 billion. First-quarter sales increased 4 ...

Over the past few years, Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device business, but it was later able to smooth out those ...

Oct 7 (Reuters) - Abbott Laboratories (ABT.N), opens new tab on Wednesday released early data from a study on the accuracy of its ID NOW COVID-19 test, which is used in the White House, that could ...

Sales growth in the medical devices segment drove Abbott Laboratories’ expectations-beating revenue in the past financial quarter as the company faces lower demand for COVID-19 tests, it reported ...

Abbott Laboratories reported strong Q4 2023 earnings, with year-over-year growth in EPS and revenue. The company's 2024 guidance projects further growth and improved ...